Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VIVUS Inc (NASDAQ:VVUS)

1.24
Delayed Data
As of Sep 02
 +0.07 / +5.98%
Today’s Change
0.94
Today|||52-Week Range
4.82
-56.94%
Year-to-Date

Today’s Trading

Previous close1.17
Today’s open1.18
Day’s range1.13 - 1.24
Volume2,203,931
Average volume (3 months)1,362,894
Market cap$129.0M
Dividend yield--
Data as of 09/02/2015

Growth & Valuation

Earnings growth (last year)+53.49%
Earnings growth (this year)-17.25%
Earnings growth (next 5 years)+0.84%
Revenue growth (last year)+40.82%
P/E ratioNM
Price/Sales2.61
Price/Book1.56

Competitors

 Today’s
change
Today’s
% change
ARGSArgos Therapeutics I...-0.04-0.64%
AKAOAchaogen Inc+0.28+4.15%
JNPJuniper Pharmaceutic...+0.62+5.57%
GLYCGlycoMimetics Inc-0.04-0.57%
Data as of 09/02/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$114.2M
Annual profit (last year)-$82.6M
Net profit margin-72.38%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Seth H. Z. Fischer
Vice President-US Operations &
General Manager
Guy P. Marsh
Corporate headquarters
Mountain View, California

Forecasts

Partner Offers